Literature DB >> 21279859

Risk factors for a first epileptic seizure symptomatic of brain tumour or brain vascular malformation. A case control study.

Maurizio A Leone1, Andrei V Ivashynka, Maria C Tonini, Graziella Bogliun, Vittorio Montano, Carlo Ravetti, Paola Gambaro, Francesco Paladin, Ettore Beghi.   

Abstract

PRINCIPLES: The risk of seizures increases in patients with brain tumours (BT) and brain vascular malformations (BVM), but not all risk factors are known. We aimed to identify factors that increase the risk of a first seizure in patients with BT or BVM.
METHODS: Multicentre case-control study; 102 cases with a first seizure as a presenting symptom of BT or BVM; 121 hospital controls with BT or BVM, but without seizures, matched by centre, gender and age.
RESULTS: In the univariate analysis, the risk of first seizure (Odds Ratio, 95% Confidence Limits) was 6.4 (2.3-17.6) for supratentorial lesions, 4.7 (2.4-9.3) for cortical involvement, 2.5 (1.0-7.7) for family history of seizures, and 2.1 (1.2-4.1) for frontal location. The types of lesion with higher risk were low grade glioma (4.7; 1.7-13.9) and cavernous malformations (13.2; 2.1-58.0). After multivariate analysis, including all the imaging characteristics and family history, the strongest independent predictors of first seizure were cortical involvement (OR 4.0; 2.0-8.1) and type of lesion (low grade glioma: 4.0; 1.3-12.8; cavernous malformations: 12.6 (1.5-103.5).
CONCLUSIONS: Cortical involvement and type of lesion are the independent risk factors for a first-ever seizure as a presenting symptom of BT or BVM.

Entities:  

Mesh:

Year:  2011        PMID: 21279859     DOI: 10.4414/smw.2011.13155

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  1 in total

1.  Factors associated with epileptic seizure of cavernous malformations in the central nervous system in West China.

Authors:  Cheng Huang; Ming-Wan Chen; Yang Si; Jin-Mei Li; Dong Zhou
Journal:  Pak J Med Sci       Date:  2013-09       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.